Skip to main content

Month: March 2022

Hanmi Financial Corporation Named a Top-20 Performing Large Community Bank by S&P Global Market Intelligence

LOS ANGELES, March 25, 2022 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), the holding company for Hanmi Bank, announced today that it was named by S&P Global Market Intelligence as one of the top-performing community banks in the United States. Hanmi was ranked No. 16 in S&P Global Market Intelligence’s 2021 Top 50 Community Banks with assets between $3 billion and $10 billion. “We’re thrilled to be recognized among the nation’s top large community banks,” Bonnie Lee, President and Chief Executive Officer of Hanmi Financial Corporation, said. “Our strong 2021 financial performance is reflective of the strategic expansion of our product and service offerings and diversifying our loan and deposit portfolios. By working closely with our customers, we further strengthened our portfolio and asset...

Continue reading

Alkame Holdings Subsidiary West Coast Copacker in Negotiations to Double Production Facility Size

LAS VEGAS, March 25, 2022 (GLOBE NEWSWIRE) — Alkame Holdings, Inc. (OTC PINK: ALKM), a publicly traded diversified holding company, is pleased to announce that its wholly owned subsidiary West Coast Co Packer, Inc. is in negotiations to substantially expand its footprint and manufacturing and Co-packing operations in Salem, Oregon. About West Coast Co Packer, Inc. West Coast Co Packer, Inc., is a wholly owned subsidiary of Alkame Holdings, Inc. and is a specialty liquid and single-serve manufacturer, co-packer, private labeler, and contract manufacturer, and is expected to immediately complement and seamlessly integrate with Alkame’s other subsidiaries including Bell Food and Beverage, Inc. Bell Food and Beverage, Inc. is a specialty natural, organic liquid-based hot and cold fill food & beverage manufacturer in glass and...

Continue reading

Pharmagest Interactive: 2021 Net Profit: +25.97% to €41.15m and new name proposal for the Group

Villers-lès-Nancy, 25 March 2022 – 7:00 p.m. (CET) PRESS RELEASE High quality, strong and profitable growth2021 Net Profit: +25.97% to €41.15mRevenue: +12.41% to €193.07mAll Divisions contributed to this performance. With the integration of PROKOV EDITIONS in Q4 2021, Pharmagest Group confirms the relevance and effectiveness of its expanded offering with a specific range of software solutions for office-based private practitioners.Solid earnings growth:Operating Profit: +8.95% to €50.26m Net Profit: +25.97% to €41.15m Basic Earnings per Share: +27.78% to €2.60.Dividend proposal for FY 2021: €1.05 per share (+10.5%).The Group’ profit margin remained steady in 2021 (26.13% vs. 27.16% in 2020) while confirming the flexibility and scalability of its ecosystem for integrating new activities and/or businesses (in 2021,...

Continue reading

Urbana Corporation Has Filed Audited 2021 Annual Financial Statements

/NOT FOR DISTRIBUTION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE U.S./ TORONTO, March 25, 2022 (GLOBE NEWSWIRE) — Urbana Corporation (TSX & CSE: URB & URB.A) Urbana Corporation announces today that it has filed its audited Financial Statements and Management’s Discussion and Analysis for the year ended December 31, 2021 with the applicable Canadian securities regulators. PDF versions of the documents are available at www.urbanacorp.com and at www.sedar.com. For further information contact: Elizabeth Naumovski Investor Relations (416) 595-9106 enaumovski@urbanacorp.com

Continue reading

CORRECTION – Life Clips, Inc. Provides Webcast Information For Its Annual Shareholders’ Meeting And Business Update

Life Clips, Inc. is re-distributing this press release initially dated on March 25, 2022 to correct the links for its Virtual Shareholders’ Update webcast on March 29, 2022 at 4:30 p.m. EST. Shareholders who have already registered will need to register again using the link below. AVENTURA, Fla., March 25, 2022 (GLOBE NEWSWIRE) — Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) would like to provide the necessary information for analysts and investors to access its Annual Shareholders’ Meeting And Business Update webcast on March 29, 2022 at 4:30 p.m. EST. Speakers on the call from Life Clips will be Robert Grinberg, Life Clips’ CEO; Victoria Rudman, the Company’s CFO; Praveen Kumar, President of Belfrics and Board Member; and Manideep Gopishetty, President Cognitive Apps and Board Member. Management will answer questions...

Continue reading

BIC: Release of BIC’s 2021 Universal Registration Document

FOR IMMEDIATE RELEASE                         Release and Availability of BIC’s2021 Universal Registration Document Clichy, France – 25 March 2022 – The French version of the 2021 Universal Registration Document was filed with the A.M.F (Autorité des Marchés Financiers: French Financial Markets Authority) on March 25, 2022. The document is available on BIC’s website in the Investors’ section under Publication as well as on the website of the A.M.F. It is also available at no cost at Société BIC’s headquarters, 14 rue Jeanne d’Asnières | 92611 Clichy Cedex. The 2021 Universal Registration Document contains XBRL tags (eXtensible Business Reporting Language) for its financial statements, as BIC decided to early adopt the European Single Electronic Format (ESEF). The document includes:Extracts from the Integrated Report, the Annual...

Continue reading

Hofseth Biocare ASA: HBC ANNUAL REPORT 2021

Today, 25 March 2022, the Board of Directors of Hofseth BioCare ASA approved the Annual Report for 2021. Please find the Annual Report 2021 and ESG Report attached. For further information, please contact:Jon Olav Ødegård, CFO of Hofseth BioCare ASAPhone: +47 93632966E-mail: joo@hofsethbiocare.no About Hofseth BioCare ASA HBC is a Norwegian consumer and pet health ingredient supplier and an incubator for new drug leads. Research is ongoing to identify the individual elements within its ingredients that modulate inflammation and the immune response with pre-clinical studies in multiple clinics and university research labs in several countries. Lead clinical and pre-clinical candidates are focused on developing an oral pharmaceutical lead program to treat inflammatory disease driven by eosinophils. Preclinical trial work with the oil is...

Continue reading

Atlantic American Corporation Reports Fourth Quarter and Year End Results for 2021; Declares Annual Dividend

ATLANTA, March 25, 2022 (GLOBE NEWSWIRE) — Atlantic American Corporation (Nasdaq- AAME) today reported net income for the three month period ended December 31, 2021 of $2.7 million, or $0.12 per diluted share, as compared to net income of $11.8 million, or $0.54 per diluted share, for the comparable period in 2020. For the year ended December 31, 2021, the Company reported net income of $4.3 million, or $0.19 per diluted share, as compared to net income of $12.2 million, or $0.56 per diluted share for the comparable period in 2020. The decrease in net income during the fourth quarter of 2021 was primarily due to an $8.0 million decrease in unrealized gains in equity securities as a result of fluctuation in market values of the Company’s equity investments still held. The decrease in net income for the year ended December 31, 2021...

Continue reading

Annual General Meeting – Summary

Company announcementMarch 25, 2022Announcement No. 7/2022 Annual General Meeting – SummaryThe Annual General Meeting of Nilfisk Holding A/S was held today, Friday March 25, 2022. Resolutions adopted at the Annual General MeetingApproval of the audited Annual Report 2021, including the Board of Director’s proposal that this year’s profits are transferred to retained comprehensive income and consequently no dividend will be distributed. Discharge of Management and the Board of Directors from their liabilities. Approval of the Remuneration Report 2021 (advisory vote). The Board of Director’s proposal for remuneration to the Board of Directors for 2022.Elections As proposed by the Board of directors, René Svendsen-Tune, Jutta af Rosenborg, Thomas Lau Schleicher, Richard P. Bisson, Are Dragesund, and Franck Falezan were re-elected...

Continue reading

THOR Industries Announces Changes to Innovation Team Leadership

ELKHART, Ind., March 25, 2022 (GLOBE NEWSWIRE) — THOR Industries, Inc. (NYSE: THO) today announced the hiring of McKay Featherstone, currently Airstream’s Vice President of Product Development and Engineering, as the company’s Senior Vice President of Global Innovation. Josef Hjelmaker, who currently serves as the company’s Chief Innovation Officer since September of 2020, has begun transitioning his duties to Mr. Featherstone, and will provide continuous advice for a seamless transition and execution. “Josef joined us in the middle of the pandemic and we assigned him the very specific and difficult task of bringing our eMobility strategy to life. The first step, from design to actual product in complicated vehicles like our electric RVs, is an incredibly challenging one. Josef fully met that challenge and delivered what is best...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.